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Ion-pair complexAbstract A simple and sensitive spectroﬂuorimetric method has been developed for the determina-
tion of doxepin hydrochloride in pharmaceutical preparations. It is based on the formation of
ion-pair complex between doxepin and alizarin red S at pH 3.09. The ion pair complex was
extracted in dichloromethane and the ﬂuorescence intensity was measured at 560 nm after excita-
tion at 490 nm. The optimum conditions for determination were also investigated. The linear range
and detection limit were found to be 2–14 and 0.55 lg/ml, respectively. The method has been
successfully applied for the analysis of drug in commercial dosage forms. No interference was
observed from common pharmaceutical adjuvant. Statistical comparison of the results obtained
by the proposed method with that of the reference method shows excellent agreement and indicates
no signiﬁcant difference in accuracy and precision.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Doxepin hydrochloride is a dibenzoxepin class of
antidepressants. It is chemically known as 1-propanamine,3-
dibenz[b,e]oxepin-11(6H)-ylidine-N,N-dimethyl-hydrochloride
with a molecular weight of 315.8. It is a white crystalline solidreadily soluble in water. The inert ingredients used in the
formulations are magnesium stearate, sodium lauryl sulfate
and starch. It has been widely used as an effective tricyclic
antidepressant in the treatment of psychiatric disorders over
the past decades (Chlobowska et al., 2003; Uddin et al.,
2008). The starting daily dose of 75 mg is recommended for
patients with mild to moderate severity. The dosage may be in-
creased or decreased depending upon the patient’s response.
The usual optimum dosage range is 75–150 mg/day. However,
overdoses of doxepin hydrochloride may lead to some
disorders like cardiac arrhythmias, severe hypotension and
hypothermia among other disorders (Gossel and Bricker,
1994; Lara et al., 2005). In view of above considerations, an
analytical procedure is needed for quality assurance in
pharmaceutical preparations.
S1178 N. Rahman, A. KhatoonUnited States Pharmacopoeia (The United States, 2008)
described a liquid chromatographic method for the assay of
doxepin hydrochloride in bulk and formulations. Literature
survey reveals that the reported methods mainly focus on chro-
matographic techniques for the determination of doxepin
hydrochloride such as TLC-densitometry (Maslanka and
Krzek, 2005), reversed-phase liquid chromatography coupled
with UV detector (Ruiz-Angel et al., 2003), ESIMS detector
(Gritti and Guiochan 2005), HPLC (Samanidou et al., 2007;
Titier et al., 2007; Ma et al., 2009), micellar electrokinetic chro-
matography (Oteen and Zeinab, 2005; Devasish et al., 2005),
GC (Tatarulu, 2006) and capillary zone electrophoresis
(Kou et al., 2004). In addition to these, several other methods
are also available for the determination of doxepin hydrochlo-
ride which includes electrogenerated chemiluminescence
(Greenway and Dolman, 1999), resonance light scattering
(Wu et al., 2007), polarography (Chodkowski et al., 1992)
and electrochemical sensor (Huang et al., 2010). However, pro-
cedures involving HPLC and capillary zone electrophoresis are
highly expensive while TLC methods are not sensitive and also
tedious to adopt for routine analysis. GC methods suffer from
thermal instability and tedious sample preparation steps. The
applications of polarography in a routine analysis of doxepin
may be restricted due to the toxicity of dropping mercury
electrode and its sluggish response.
Procedures involvingspectrophotometryandspectroﬂuorimetry
have attracted because of their sensitivity, speed and simplicity.
One of the advantages is that most of the additives or excipients
found in formulations are non-ﬂuorescent in nature and
hence, spectroﬂuorimetry is a good choice for quantitative anal-
ysis of drugs in commercial dosage forms. Literature survey re-
vealed that few spectroﬂuorimetric methods have been
reported for the determination of doxepin. A semi automatic
extraction-ﬂuorimetric method (Acedo-Valenzuela et al.,
2005) for the determination of doxepin based on the ion-pair
formation with 9,10-dimethoxyanthracene-2-sulfonate has
been reported. In addition, extractive ﬂuorimetric methods
based on the ﬂuorescent ion pair complex formation of the
drug with eosin Y (Rahman et al., 2009) and tetraiodoﬂuores-
cein (Devriendt et al., 1973) have also been reported for their
assay in pharmaceutical preparations and biological ﬂuids.
Spectrophotometric methods have also been developed for
quantitation of doxepin hydrochloride involving the reagents
such as titanium(IV) thiocyanate and iron(III) thiocyanate
(Misiuk, 2005), Reinecke salt (Kurzawa et al., 1999), 3-methyl
benzothiazolin-2-one hydrazone (Revanasiddappa and
Manju, 1999) and bromophenol blue (Shingbal and Rao,
1985).
This work describes a new spectroﬂuorimetric method for
the determination of doxepin hydrochloride in bulk and
pharmaceutical preparations. The proposed method is based
on the formation of an ion-pair complex between doxepin
and alizarin red S at pH 3.09. The ion-pair complex was
completely extracted into dichloromethane which showed
ﬂuorescence intensity at 560 nm after excitation at 490 nm.
The proposed method offers the advantage of simplicity
with respect to reagent, good sensitivity and stability. The
reaction conditions were optimized and validated as per
guidelines of International Conference on Harmonization
(ICH, 1995).2. Experimental
2.1. Apparatus
All ﬂuorescence spectra were recorded on a Hitachi ﬂuores-
cence spectrophotometer F-2500 (Tokyo, Japan) equipped
with a xenon lamp. All measurements took place in quartz cells
with path length 1.0 · 1.0 cm. Eutech (Cyber scan pH 2100)
pH meter was used to measure the pH. All measurements were
performed at 25 ± 1C. The infra red spectra were recorded
on a Perkin–Elmer FTIR 1650 spectrophotometer using KBr
pellet technique.
2.2. Reagents
Doxepin hydrochloride was obtained from Sigma Chemical
Company (St. Louis, MO, USA) and used as received.
Spectra-10 capsules (Rexin Pharmaceuticals Private Limited,
Himachal Pradesh, India), labeled to contain 10 mg doxepin
hydrochloride per capsule, were purchased from local drug
stores. Buffer solutions ranging from pH 0.91–5.20 were
prepared by mixing 50 ml of 1 N sodium acetate and an appro-
priate volume of 1 N HCl and diluted to 250 ml with distilled
water (Britton, 1932) and 2.74 · 103 M alizarin red S (Fluka
Chemie AG, Switzerland, M.W. 342.26) solution was freshly
prepared in distilled water.
2.3. Preparation of standard solution
An accurately weighed amount (50 mg) of doxepin hydrochlo-
ride was transferred into a 50 ml standard ﬂask, dissolved in
20 ml distilled water and then completed to the mark with
the same solvent to obtain a stock solution of 1 mg/ml. This
stock solution was further diluted with water to obtain a
standard working solution of 0.1 mg/ml.
2.4. Procedure for determination of doxepin hydrochloride
Accurately measured aliquots of the working standard solu-
tion of doxepin hydrochloride (0.1 mg/ml) equivalent to
20–140 lg were transferred into a series of 50 ml separating
funnels. To each funnel, 1.5 ml of buffer solution (pH 3.09)
was added followed by 3.0 ml of 0.1% alizarin red S. The
contents of separating funnel were shaken well with 2 · 5 ml
dichloromethane for 1.5 min and then allowed to separate
the two layers. The ﬂuorescence intensity of the organic layer
was measured at 560 nm after excitation at 490 nm. The
ﬂuorescence intensity was plotted against the concentration
of the drug to get the calibration graph and the corresponding
regression equation was also developed.
2.5. Analysis of commercial tablets
The powder contents of ﬁve capsules of 10 mg strength of
doxepin hydrochloride were treated with 50 ml distilled water
and left for 10 min for a complete extraction of the drug.
The aqueous extract was ﬁltered through Whatmann No. 42
ﬁlter paper (particle retention: 2.5 lm; Whatmann Interna-
tional Limited, Kent, UK) in a 100 ml volumetric ﬂask. The
residue was washed with distilled water and then completed
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Figure 1 Excitation and emission spectra of ﬂuorescent ion-pair
complex.
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Spectroﬂuorimetric determination of doxepin hydrochloride in commercial dosage forms via ion S1179to the volume with distilled water. The prepared solution was
diluted quantitatively with distilled water to obtain a suitable
concentration for analysis by the proposed method.
2.6. Determination of stoichiometry
Job’s method of continuous variations (Skoog et al., 2004) was
applied for ascertaining the stoichiometry of the ion-pair com-
plex. This was achieved by combining different volumes, i.e.
0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8 and 0.9 ml of doxepin hydro-
chloride (2.74 · 103 M) with 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2
and 0.1 ml, of alizarin red S (2.74 · 103 M), respectively, into
a 50 ml separating funnel. The contents of the funnel were sha-
ken vigorously with 2 · 5 ml dichloromethane and then al-
lowed to stand for clear separation of the organic phase. The
ﬂuorescence intensity was measured at 560 nm after excitation
at 490 nm and plotted against the mole fraction of the drug.
2.7. Procedure for reference method (Revanasiddappa and
Manju, 1999)
Portions of standard doxepin hydrochloride solution (0.1 mg/
ml) corresponding to 0.5–3.0 lg/ml were pipetted into a series
of 10 ml volumetric ﬂask. To each ﬂask 1 ml of 0.4% 3-meth-
ylbenzthiazolinone-2-hydrazone solution and 3 ml of 1%
iron(III) chloride solution prepared in 1 M hydrochloric acid
were added and diluted to the mark with distilled water. The
contents of the solution were mixed thoroughly and the
absorbance of the solution was measured after 50 min at
620 nm against the reagent blank prepared simultaneously
except the drug .The amount of the drug in a given sample
can be estimated either from the calibration graph or the
corresponding linear regression equation.Mole fraction of drug
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Figure 2 Job’s plot to establish the stoichiometry of the reaction.3. Results and discussion
Doxepin hydrochloride is non-ﬂuorescent in nature and hence,
its derivatization with a ﬂuorogenic reagent is necessary for
its determination by spectroﬂuorimetry. The ﬂuorogenic
reagents such as 9,10-dimethoxyanthracene-2-sulfonate
(Acedo-Valenzuela et al., 2005), tetraiodoﬂuorescein (Devriendt
et al., 1973) and eosin Y (Rahman et al., 2009) have been
found to form the ﬂuorescent ion-pair complex with doxepin
in acidic medium. The resulting ion-pair complexes were
quantitatively extracted into dichloromethane and determined
spectroﬂuorimetrically. The reaction of doxepin with alizarin
red S has not been investigated yet. Therefore, the present
study was devoted to investigate the reaction of doxepin with
alizarin red S and employment of the reaction in the develop-
ment of a sensitive and simple spectroﬂuorimetric method for
its determination in pharmaceutical preparations. In the
present study aqueous solution of doxepin hydrochloride was
found to react with alizarin red S at pH 3.09 resulting in the
formation of the ﬂuorescent ion-pair complex which was
quantitatively extracted into dichloromethane. The excitation
and emission spectra are shown in Fig. 1.
3.1. Stoichiometry and reaction mechanism
The stoichiometry of the reaction between doxepin and aliza-
rin red S was investigated by Job’s method. Job’s plot(Fig. 2) has revealed that the molar combining ratio between
doxepin and alizarin red S is 1:1. The apparent formation con-
stant and Gibb’s free energy (DG) were calculated and found to
be 1.56 · 106 and 35.31 kJ/mol, respectively.
Doxepin is a derivative of dibenzoxepine and its basic char-
acteristics are due to the presence of tertiary amino group in
the aliphatic chain. In acidic medium doxepin is protonated
while alizarin red S (3,4-dihyroxy-9,10-dioxo-2-anthracene
sulfonic acid sodium salt) ionizes in aqueous solution provid-
ing a negative charge on it. Thus one mole of doxepin reacted
with one mole of alizarin red S resulting in the formation of
ﬂuorescent ion-pair complex which is easily extractable in
dichloromethane.
The infra red spectra of doxepin hydrochloride, alizarin red
S and the doxepin-alizarin red S ion pair complex were re-
corded in the region 4000–400 cm1. The results are presented
in Fig. 3. Some characteristic frequencies are listed in Table 1.
The IR spectrum of the complex shows bandcharacteristics for
functional groups of doxepin and alizarin red S, such as:
(i) Presence of N+–H at 2693 cm1, (–CH2–)2 at 764 cm1,
(–C–O–C–) at 1005 cm1 conﬁrms the presence of doxe-
pin in the complex.
Figure 3 IR Spectra of a – doxepin hydrochloride; b – Alizarin
red- S; c – doxepin-alizarin red-S ion-pair complex.
S1180 N. Rahman, A. Khatoon(ii) Presence of C–S at 633 cm1, –SO3 at 1275, 1219 and
1053 cm1 authenticates the involvement of alizarin red
S in the complex formation.
Based on the combining ratio and literature background,
the reaction pathway between doxepin and alizarin red S was
postulated to proceed as shown in Scheme 1.
3.2. Optimization of experimental conditions
To optimize the assay variables, the effects of concentration of
alizarin red S, reaction time, pH, extracting solvent and shak-
ing time for extraction on the ﬂuorescence intensity of the ion-
pair complex formed were carefully studied.
3.2.1. Effect of volume of reagent
The effect of volume of 2.74 · 103 M alizarin red S on the
ﬂuorescence intensity was studied in the range of 0.5–3.4 ml;
keeping the amount of the drug (10 lg/ml) constant. The
results are shown in Fig. 4. The maximum ﬂuorescence inten-
sity was obtained with 2.7 ml of the reagent. At higher volumes
of 2.74 · 103 M alizarin red S up to 3.4 ml, the ﬂuorescence
intensity was not affected. Thus, a volume of 3.0 ml of
2.74 · 103 M alizarin red S was chosen as an optimum
volume for all measurements.
3.2.2. Effect of reaction time
The effect of reaction time on the formation of ion-pair
complex was studied at 25 ± 1 C. It was observed that theTable 1 Representative infra red frequencies of doxepin hydrochlo
m(N+–H) m(C‚O)
Doxepin HCl 2692 –
Alizarin red S – 1639
Doxepin-alizarin red S ion-pair complex 2693 1639complex got stabilized immediately after mixing the drug
and reagent and remained stable for about 1 h.
3.2.3. Effect of pH
The effect of pH on the formation of ion-pair complex was
studied by carrying out the reaction in sodium acetate–HCl
buffer solution of pH 0.91–5.20. It was evident from Fig. 5 that
maximum ﬂuorescence intensity was obtained at pH 3.09. In
order to keep the high sensitivity for the determination of dox-
epin hydrochloride, the subsequent experiments were carried
out at pH 3.09.
3.2.4. Effect of volume of pH 3.09 buffer solution
The effect of volume of pH 3.09 buffer solution on the ﬂuores-
cence intensity was investigated in the range of 0.5–2.0 ml
(Fig. 6). The highest ﬂuorescence intensity was obtained with
1.5 ml of buffer (pH 3.09) solution, beyond this, a further in-
crease in the volume of buffer solution resulted in no change
in the ﬂuorescence intensity of the complex. Therefore,
1.5 ml of pH 3.09 buffer solution was adopted as an optimum
volume for ﬂuorescence measurements.
3.2.5. Solvent effect
In order to select the most appropriate solvent for extracting
the ion-pair complex, different solvents were tested such as
chloroform, carbon tertrachloride, dichloromethane, dichloro-
ethane and ethyl acetate. The maximum ﬂuorescence intensity
was obtained when extraction was carried out with dichloro-
methane. Therefore, dichloromethane was chosen as the most
appropriate solvent for the extraction of ion pair complex.
3.2.6. Effect of shaking time for extraction
The effect of the shaking time for the extraction of ion-pair
complex in dichloromethane was studied in the range of
0.5–2.5 min. The maximum ﬂuorescence intensity of the
complex was obtained at 1.0 min shaking and above this up
to 2.5 min, the ﬂuorescence intensity remained constant.
Therefore, 1.5 min was used as an optimum shaking time
throughout the determination process. The ion-pair complex
was quantitatively recovered in two extractions.
4. Method validation
4.1. Linearity and limits of detection and quantitation
Under the optimized experimental conditions, the calibration
curve was constructed by plotting ﬂuorescence intensity as a
function of the corresponding doxepin hydrochloride concen-
tration (Fig. 7). The linear relationship was obtained in theride, alizarin red S and doxepin-alizarin red S ion-pair complex.
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Spectroﬂuorimetric determination of doxepin hydrochloride in commercial dosage forms via ion S1181concentration range of 2–14 lg/ml. The regression analysis of
calibration data gave the regression cited in Table 2 with a cor-
relation coefﬁcient of 0.9995. The limit of detection (LOD) and
limit of quantitation (LOQ) were calculated according to the
ICH guidelines for validation of analytical procedures (Tatar-
ulu, 2006). The LOD and LOQ values were found to be 0.55
and 1.82 lg/ml, respectively. The parameters for analytical per-
formance of the proposed method are summarized in Table 2.
4.2. Precision and repeatability
To evaluate intra-day and inter-day precisions, analysis of dox-
epin hydrochloride at three concentration levels (2, 4, 6) lg/ml
was carried out by performing ﬁve experiments on the same day
using the same analyte standard solution and over ﬁve consec-
utive days using different solutions. The results are summarized
in Table 3. The intra-day and inter-day RSD values ranged
from 0.05% to 0.37% and 0.02% to 0.30%, respectively,
reﬂecting the usefulness of the method in routine use.4.3. Accuracy and recovery
The accuracy of the proposed method was tested by perform-
ing recoveryexperiments through standard addition technique.
For this known quantities of pure doxepin hydrochloride were
mixed with deﬁnite amounts of preanalyzed commercial dos-
age forms and mixtures were analyzed following the proposed
method. The results are reported in Table 4. The percent
recoveries obtained were quantitative (99.64–100.6%) indicat-
ing the good accuracy of the method.
4.4. Selectivity
The selectivity of the proposed method was evaluated by ana-
lyzing the standard solution of doxepin hydrochloride in the
presence of tablet excipients such as lactose, sucrose, mannitol,
starch and magnesium stearate. It was observed that these
excipients did not interfere with the proposed method. The
results of the recovery experiment also indicated that neither
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0
50
100
150
200
250
300
350
Volume of 2.74 x 10-3M alizarin
Fl
uo
re
sc
en
ce
 In
te
ns
ity
Figure 4 Effect of volume of 2.74 · 103 M alizarin red S on the
ﬂuorescence intensity of complex (doxepin hydrochloride 10 lg/
ml).
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Figure 7 Calibration curve for determination of doxepin
hydrochloride.
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Figure 6 Effect of the volume of pH-3.09 buffer solution on the
ﬂuorescence intensity of the ion-pair complex.
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Figure 5 Effect of pH on the ﬂuorescence intensity of the ion-
pair complex.
Table 2 Statistical parameters for the determination of
doxepin by the proposed method.
Parameters Value
kex (nm) 490
kem (nm) 560
Linear range (lg/ml) 2–14
Intercept, a 113.6
Slope, b 22.203
Correlation coeﬃcient (r) 0.9995
LOD (lg/ml) 0.55
LOQ (lg/ml) 1.82
S1182 N. Rahman, A. Khatoonthe accuracy nor the precision of the proposed method is af-
fected by the coformulated substances.
4.5. Robustness
The method robustness was tested by varying several parame-
ters and studying the effect on the ﬂuorescence intensity. The
effect of varying the volumes of 2.74 · 103 M alizarin red S
solution from 2.8 to 3.4 ml was examined. It was found that
there was no change in the ﬂuorescence intensity of the com-
plex. The study of variation of volume of buffer solution of
pH 3.09 from 1.3 to 1.7 ml showed that it did not affect the
percentage recovery of the drug. Results of variation in the
experimental parameters, as well as carrying out the experi-
ment at room temperature, proved their reliability during the
normal use and suggested that the proposed method is robust.
5. Application
The proposed method was applied to the determination of
doxepin hydrochloride in commercial formulations. Five repli-
cate determinations were made using the proposed method and
the reference method (Revanasiddappa and Manju, 1999). The
results are summarized in Table 5. The results were reproduc-
ible with low RSD values. The results obtained for the analysis
Table 3 Test of precision of the proposed method.
Proposed method Concentration (lg/ml) RSD% SAEb C.Lc
Taken Founda ± SD
Intraday 2.00 2.006 ± 0.010 0.05 0.005 0.012
7.00 7.035 ± 0.011 0.16 0.005 0.013
12.00 12.037 ± 0.448 0.37 0.200 0.556
Interday 2.00 2.001 ± 0.015 0.07 0.007 0.018
7.00 7.030 ± 0.014 0.02 0.006 0.017
12.00 12.031 ± 0.036 0.30 0.016 0.044
a Mean for ﬁve independent determinations.
b SAE, standard analytical error.
c C.L., conﬁdence limit at 95% conﬁdence level and four degrees of freedom (t= 2.776).
Table 4 Recovery of doxepin hydrochloride by standard addition technique.
Concentration (lg/ml)
Spectra-10 (taken) Standard added Found ± SD R.S.D (%) Recoverya (%)
6 3 8.968 ± 0.050 0.56 99.64
6 5 11.068 ± 0.068 0.61 100.61
6 6 12.041 ± 0.070 0.58 100.34
a Mean for ﬁve independent analyses.
Table 5 Applicability of the proposed method in pharmaceutical formulations and its comparison with the reference method
(Revanasiddappa and Manju, 1999).
Pharmaceutical formulation
Tablet
Proposed method Reference method t and F valueb hL
c hU
c
Recoverya(%) RSD (%) Recoverya (%) RSD (%)
Spectra-10 100.12 0.41 100.19 0.43 t= 0.264, F= 1.1004 0.992 1.006
a Mean for ﬁve independent analyses.
b Theoritical t (m= 8) and F values at 95% conﬁdence level are 2.306 and 6.39, respectively.
c A bias, based on recovery experiments, of ±2% is acceptable.
Spectroﬂuorimetric determination of doxepin hydrochloride in commercial dosage forms via ion S1183of doxepin hydrochloride in drug formulation were compared
statistically with those obtained by reference method. Stu-
dent’s t-test and F-test values at 95% conﬁdence level did
not exceed the theoretical value of 2.306 and 6.39 for t-test
and F-test, respectively; indicating no signiﬁcant difference be-
tween the performances of the methods compared regarding
accuracy and precision. The interval hypothesis (Hartman
et al., 1995) test has also been performed to check the reliabil-
ity of the proposed method by calculating the lower (hL) and
upper (hU) acceptance limits using the equation:
h2 X21  S2Pt2tab=n1
  2hx1  x2 þ h2 X22  S2Pt2tab=n2
  ¼ 0 ð1Þ
The values of hL and hU of the conﬁdence interval were
obtained as:
hL ¼ b ðb2  4acÞ1=2=2a ð2Þ
hU ¼ bþ ðb2  4acÞ1=2=2a ð3Þ
where
a ¼ X21  S2pt2tab=n1 ð4Þb ¼ 2 X1 X2 ð5Þ
c ¼ X22  S2pt2tab=n2 ð6Þ
The values of hL and hU are reported in Table 5. It is concluded
based on hL and hU values that the proposed method is not
biased because the true bias is smaller than ±2.0%; indicating
the compliance of regulatory guidelines (Acceptable methods,
1992).
The performance of the proposed method was compared
with other existing methods (Table 6). It is evident that the
present method has a wider linear range with low values of
LOD and RSD as compared to the existing spectroﬂuorimetric
method (Rahman et al., 2009) suitable for the determination of
doxepin hydrochloride in pharmaceutical preparations. The
proposed method is also simpler than the spectrophotometric
methods (Devriendt et al., 1973; Misiuk, 2005; Kurzawa,
1999) requiring less analysis time. The polarographic method
is not usually recommended owing to the toxicity of dropping
mercury electrode. HPLC is more sensitive but involves expen-
sive instrumental set up which an ordinary laboratory cannot
Table 6 Comparison of performance of the proposed method with other existing methods for determination of doxepin
hydrochloride.
Techniques/reagents Linear range (lg/ml) LOD (lg/ml) RSD (%) References
Spectroﬂuorimetry
Eosin Y 0.1–0.8 0.95 0.59 Rahman et al. (2009)
Alizarin red S 2.0–14 0.55 0.41 This work
Spectrophotometry
3-Methyl benzothiazolin-2-one hydrazone 0.8–10 – 1.1 Revanasiddappa and Manju (1999)
Titanium(IV) thiocyanate 5–50 0.34 0.43 Misiuk (2005)
Iron (III) thiocyanate 3–30 0.26 0.32 Misiuk (2005)
Reinecke salt 30–450 – 1.69 Kurzawa et al. (1999)
Densitometric - TLC 131.3–1050 0.033 1.89 Maslanka and Krzek (2005)
Polarography 10–50 – 0.94 Chodkowski et al. (1992)
Reversed-phase liquid chromatography 30–70 – <2.0 Ruiz-Angel et al. (2003)
Electrochemical sensor 3.158 · 104–3.158 · 104 3.158 · 105 2.5 Huang et al. (2010)
S1184 N. Rahman, A. Khatoonafford. Thus, the proposed method is most suitable for a rou-
tine analysis of doxepin in commercial dosage forms.
6. Conclusions
The proposed method does not require any laborious clean up
procedure before measurement. In addition the method shows
good accuracy and precision. The method shows no interfer-
ences from the common excipients and additives. The statisti-
cal parameters and recovery data revealed good accuracy and
precision of the proposed method. Therefore, it is concluded
that the proposed method is simple, sensitive and rapid for
the determination of doxepin hydrochloride in commercial
dosage forms.Acknowledgement
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